Amedisys Historical Income Statement

AMED Stock  USD 92.46  0.17  0.18%   
Historical analysis of Amedisys income statement accounts such as Interest Expense of 32.8 M, Selling General Administrative of 819.1 M or Total Revenue of 2.3 B can show how well Amedisys performed in making a profits. Evaluating Amedisys income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Amedisys's future profits or losses.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Amedisys latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Amedisys is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.

About Amedisys Income Statement Analysis

Amedisys Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Amedisys shareholders. The income statement also shows Amedisys investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Amedisys Income Statement Chart

Amedisys Income Statement is one of the three primary financial statements used for reporting Amedisys's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Amedisys revenue and expense. Amedisys Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Amedisys' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 2.3 B, whereas Gross Profit is forecasted to decline to about 447.4 M.

Total Revenue

Total revenue comprises all receipts Amedisys generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Amedisys minus its cost of goods sold. It is profit before Amedisys operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Amedisys. It is also known as Amedisys overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Amedisys' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Amedisys current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.At present, Amedisys' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 2.3 B, whereas Gross Profit is forecasted to decline to about 447.4 M.
 2021 2022 2023 2024 (projected)
Gross Profit980.8M962.8M457.1M447.4M
Total Revenue2.2B2.2B2.2B2.3B

Amedisys income statement Correlations

0.20.550.610.850.60.260.250.370.360.610.180.370.150.32-0.44-0.020.26-0.010.240.280.36-0.38-0.260.74-0.21
0.20.780.730.130.690.40.360.370.88-0.05-0.530.070.390.15-0.240.060.0-0.13-0.240.40.440.69-0.940.640.8
0.550.780.970.620.880.580.590.640.940.24-0.320.40.540.45-0.660.070.23-0.310.110.750.670.23-0.730.750.48
0.610.730.970.720.960.50.470.530.930.4-0.170.340.490.39-0.690.140.16-0.140.120.650.720.15-0.70.750.42
0.850.130.620.720.720.250.240.340.420.760.280.360.220.34-0.750.010.180.050.350.50.48-0.52-0.130.53-0.28
0.60.690.880.960.720.250.190.270.880.59-0.160.080.250.13-0.730.12-0.090.140.040.470.590.17-0.620.650.39
0.260.40.580.50.250.250.950.950.53-0.390.10.920.960.96-0.040.330.89-0.840.270.730.74-0.02-0.540.660.29
0.250.360.590.470.240.190.950.990.49-0.44-0.10.90.890.92-0.10.120.85-0.90.310.790.64-0.02-0.460.560.25
0.370.370.640.530.340.270.950.990.51-0.34-0.070.910.870.93-0.160.120.85-0.860.330.790.66-0.07-0.470.640.21
0.360.880.940.930.420.880.530.490.510.13-0.370.250.520.33-0.510.180.12-0.2-0.020.590.690.46-0.840.710.69
0.61-0.050.240.40.760.59-0.39-0.44-0.340.130.28-0.28-0.37-0.31-0.65-0.06-0.430.640.1-0.040.04-0.40.130.13-0.38
0.18-0.53-0.32-0.170.28-0.160.1-0.1-0.07-0.370.280.320.150.30.10.470.350.060.32-0.080.15-0.730.380.0-0.59
0.370.070.40.340.360.080.920.90.910.25-0.280.320.850.99-0.040.270.97-0.830.420.680.61-0.37-0.230.54-0.07
0.150.390.540.490.220.250.960.890.870.52-0.370.150.850.91-0.050.310.82-0.760.330.730.81-0.03-0.510.570.3
0.320.150.450.390.340.130.960.920.930.33-0.310.30.990.91-0.040.310.96-0.840.410.710.68-0.3-0.310.570.02
-0.44-0.24-0.66-0.69-0.75-0.73-0.04-0.1-0.16-0.51-0.650.1-0.04-0.05-0.040.060.2-0.09-0.18-0.62-0.250.160.08-0.160.02
-0.020.060.070.140.010.120.330.120.120.18-0.060.470.270.310.310.060.3-0.210.120.070.37-0.01-0.230.280.16
0.260.00.230.160.18-0.090.890.850.850.12-0.430.350.970.820.960.20.3-0.830.370.510.54-0.33-0.210.49-0.07
-0.01-0.13-0.31-0.140.050.14-0.84-0.9-0.86-0.20.640.06-0.83-0.76-0.84-0.09-0.21-0.83-0.19-0.64-0.410.050.28-0.31-0.15
0.24-0.240.110.120.350.040.270.310.33-0.020.10.320.420.330.41-0.180.120.37-0.190.280.37-0.370.250.14-0.25
0.280.40.750.650.50.470.730.790.790.59-0.04-0.080.680.730.71-0.620.070.51-0.640.280.55-0.08-0.350.390.18
0.360.440.670.720.480.590.740.640.660.690.040.150.610.810.68-0.250.370.54-0.410.370.55-0.06-0.570.680.35
-0.380.690.230.15-0.520.17-0.02-0.02-0.070.46-0.4-0.73-0.37-0.03-0.30.16-0.01-0.330.05-0.37-0.08-0.06-0.570.10.85
-0.26-0.94-0.73-0.7-0.13-0.62-0.54-0.46-0.47-0.840.130.38-0.23-0.51-0.310.08-0.23-0.210.280.25-0.35-0.57-0.57-0.76-0.77
0.740.640.750.750.530.650.660.560.640.710.130.00.540.570.57-0.160.280.49-0.310.140.390.680.1-0.760.37
-0.210.80.480.42-0.280.390.290.250.210.69-0.38-0.59-0.070.30.020.020.16-0.07-0.15-0.250.180.350.85-0.770.37
Click cells to compare fundamentals

Amedisys Account Relationship Matchups

Amedisys income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization63.3M74.7M78.0M75.7M23.8M23.7M
Interest Expense14.5M11.0M9.5M22.2M31.3M32.8M
Selling General Administrative607.9M668.3M711.2M754.1M780.1M819.1M
Total Revenue2.0B2.1B2.2B2.2B2.2B2.3B
Gross Profit805.3M886.2M980.8M962.8M457.1M447.4M
Other Operating Expenses1.8B1.8B2.0B2.0B2.0B2.1B
Operating Income177.5M219.3M251.9M180.8M193.1M202.7M
Ebit177.5M219.3M251.9M180.8M193.1M202.7M
Ebitda240.7M294.0M329.9M256.4M216.9M227.8M
Cost Of Revenue1.2B1.2B1.2B1.3B1.8B1.9B
Total Operating Expenses626.4M662.7M728.8M779.0M264.0M381.3M
Total Other Income Expense Net(7.1M)(8.4M)28.3M(20.5M)(153.4M)(145.8M)
Net Income126.8M183.6M209.1M118.6M(9.7M)(9.3M)
Income Tax Expense42.5M25.6M70.1M42.5M50.6M53.1M
Income Before Tax170.4M210.8M280.2M160.2M39.6M45.7M
Net Income Applicable To Common Shares126.8M183.6M209.1M118.6M136.4M143.2M
Minority Interest1.1M1.6M1.1M(910K)1.1M1.1M
Net Income From Continuing Ops127.9M185.2M210.2M117.7M1.6M1.5M
Non Operating Income Net Other7.5M2.6M37.8M1.7M2.0M1.9M
Tax Provision42.5M25.6M70.1M42.5M50.2M42.3M
Interest Income78K292K49K178K2.5M2.6M
Net Interest Income(14.4M)(10.7M)(9.5M)(22.1M)(26.3M)(25.0M)
Reconciled Depreciation54.3M67.9M71.3M71.0M59.9M55.7M

Pair Trading with Amedisys

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amedisys position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amedisys will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Amedisys could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amedisys when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amedisys - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amedisys to buy it.
The correlation of Amedisys is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amedisys moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amedisys moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amedisys can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Amedisys Stock analysis

When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Global Correlations
Find global opportunities by holding instruments from different markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Earnings Share
(0.30)
Revenue Per Share
68.603
Quarterly Revenue Growth
0.016
Return On Assets
0.0598
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.